gemcitabine has been researched along with salinomycin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Chen, SP; Kang, T; Liang, Y; Zhang, GN; Zhang, TP; Zhao, YP; Zhou, LJ | 1 |
| Amini, M; Azizi, M; Daman, Z; Gilani, K; Montazeri, H; Ostad, SN; Rezaie, F | 1 |
| Dosch, JS; Rehemtulla, A; Sebolt-Leopold, JS; Shettigar, A; Ziemke, EK | 1 |
| Banciu, M; Berindan-Neagoe, I; Jurj, A; Rus, L; Sesarman, A; Stiufiuc, R; Tefas, LR; Toma, I; Tomuta, I | 1 |
4 other study(ies) available for gemcitabine and salinomycin
| Article | Year |
|---|---|
Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Flow Cytometry; Gemcitabine; Glycoproteins; Humans; Male; Mice; Mice, Nude; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides; Pyrans; Xenograft Model Antitumor Assays | 2011 |
Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Deoxycytidine; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Flow Cytometry; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Micelles; NIH 3T3 Cells; Pancreatic Neoplasms; Particle Size; Polyethylene Glycols; Pyrans; Solubility; Surface Properties; Xenograft Model Antitumor Assays | 2015 |
Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.
Topics: AC133 Antigen; Animals; Antigens, CD; Antigens, Ly; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CD24 Antigen; Cell Transformation, Neoplastic; Deoxycytidine; Disease Models, Animal; Gemcitabine; Glycoproteins; Luciferases; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Experimental; Neoplastic Stem Cells; Pancreas; Pancreatic Neoplasms; Peptides; Phenotype; Proto-Oncogene Proteins p21(ras); Pyrans; Spheroids, Cellular; Staining and Labeling; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2015 |
Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Deoxycytidine; Gemcitabine; Humans; Liposomes; Polyethylene Glycols | 2023 |